| 摘要 |
<p>The present invention encompasses genetically modified non-human mammals comprising a genetic modification that inhibits and/or reduces BRD1 activity in one or more tissue or cell, methods of producing the same, methods and uses for identifying compounds for treating a mental disorder and pharmaceutical formulations of said compounds.</p> |
